ABSTRACT
OBJECTIVE: To evaluate whether the quadrivalent human papillomavirus (HPV) (types 6, 11, 16, and 18) vaccine influences the clinical course of juvenile-onset recurrent respiratory papillomatosis (RRP) when administered to a group of patients with this condition. METHODS: Uncontrolled intervention study of patients with juvenile-onset RRP examined at the Pediatric Otorhinolaryngology Clinic, Federal University of São Paulo, where nine patients between the ages of nine and 17 received three doses of the prophylactic quadrivalent HPV vaccine (Gardasil(®)) and were followed for one year. Disease staging, intervals between relapses, intervals between surgeries, and the number of surgeries during the year prior to vaccination and during the first year after vaccination were compared. RESULTS: Eight patients were infected with HPV-6 and one with HPV-11. There were no statistically significant differences in the clinical scores (p=0.083), anatomical scores (p=0.257), intervals between relapses (p=0.062), intervals between surgeries (p=0.357), or the numbers of surgeries (p=0.180) when the years before and after vaccination were compared. All patients had relapses following vaccination. CONCLUSION: Patients with juvenile-onset RRP experienced a similar clinical course in the year after versus the year before vaccination with Gardasil(®).
Subject(s)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18/administration & dosage , Papillomaviridae/immunology , Papillomavirus Infections/drug therapy , Respiratory Tract Infections/drug therapy , Adolescent , Brazil , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Male , Treatment OutcomeABSTRACT
Human papillomavirus (HPV) is a DNA virus that presents tropism for epithelial cells, causing infections of the skin and mucous membranes. Replication of HPV occurs in the nuclei of squamous cells and its life cycle is directly related to the differentiation program of the host cell. To date, nearly 100 different types of HPV have been characterized and there is a large number of other types that have not been sequenced yet. Besides being responsible for benign lesions of the skin and mucous membranes, HPV is also involved in the development of various mucocutaneous tumors: Bowen's disease, non-melanoma skin cancers and genital carcinomas. This review discusses the characteristics of HPV, malignant and benign mucous and skin manifestations caused by HPV, besides the main methods of detection and typing of the virus.
Subject(s)
Papillomaviridae , Papillomavirus Infections/etiology , Skin Neoplasms/virology , Tumor Virus Infections/etiology , Warts/virology , Humans , Papillomaviridae/classification , Papillomaviridae/isolation & purification , Papillomavirus Infections/genetics , Phylogeny , Tumor Virus Infections/genetics , Tumor Virus Infections/virologyABSTRACT
O papilomavírus humano (HPV) é um vírus DNA que apresenta tropismo por células epiteliais, causando infecções na pele e nas mucosas. A replicação do HPV ocorre no núcleo das células escamosas e o seu ciclo de vida é diretamente relacionado ao programa de diferenciação da célula hospedeira. Até o momento, foram completamente caracterizados cerca de 100 tipos diferentes de HPVs e há um grande número adicional de tipos ainda não sequenciados. Além de ser o responsável por lesões benignas de pele e mucosas, o HPV também está envolvido no desenvolvimento de diversos tumores cutaneomucosos: doença de Bowen, cânceres de pele não melanoma e carcinomas genitais. Esta revisão aborda as características do HPV, quadros cutâneos e mucosos benignos e malignos causados por ele e os principais métodos empregados em sua detecção e tipagem.
Human papillomavirus (HPV) is a DNA virus that presents tropism for epithelial cells, causing infections of the skin and mucous membranes. Replication of HPV occurs in the nuclei of squamous cells and its life cycle is directly related to the differentiation program of the host cell. To date, nearly 100 different types of HPV have been characterized and there is a large number of other types that have not been sequenced yet. Besides being responsible for benign lesions of the skin and mucous membranes, HPV is also involved in the development of various mucocutaneous tumors: Bowen's disease, non-melanoma skin cancers and genital carcinomas. This review discusses the characteristics of HPV, malignant and benign mucous and skin manifestations caused by HPV, besides the main methods of detection and typing of the virus.
Subject(s)
Humans , Papillomaviridae , Papillomavirus Infections/etiology , Skin Neoplasms/virology , Tumor Virus Infections/etiology , Warts/virology , Phylogeny , Papillomaviridae/classification , Papillomaviridae/isolation & purification , Papillomavirus Infections/genetics , Tumor Virus Infections/genetics , Tumor Virus Infections/virologyABSTRACT
Os pacientes receptores de transplante renal apresentam elevada prevalência de lesões cutâneas por HPV. Foram estudados 20 receptores de transplante renal com diagnóstico de verruga vulgar. A detecção do HPV foi realizada pela polimerização em cadeia (PCR) com os primers MY09/MY11 e RK91. A tipagem do HPV foi feita por meio da restrição enzimática e do sequenciamento automatizado. Identificamos a presença do HPV em 10 pacientes (50 por cento) e os tipos identificados foram: HPV-2, 27, 29, 34 e 57.
The prevalence of skin lesions caused by the human papillomavirus (HPV) is high in kidney transplant patients. Twenty recipients of kidney transplants with a diagnosis of common warts were evaluated. HPV detection was performed by polymerase chain reaction (PCR) using the MY09/MY11 and RK91 primers. HPV typing was performed by restriction fragment length polymorphism analysis and direct sequencing. The presence of HPV was identified in 10 patients (50 percent) and the types identified were HPV-2, 27, 29, 34 and 57.
